Veterinary Dermatology Drugs Market Size to Gain Traction of $9.9 Billion, Growth Opportunities by 2031

Veterinary Dermatology Drugs Market: Introduction
According to the report, the global veterinary dermatology drugs market was valued over US$ 3.6 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Veterinary dermatology, also referred as pet skin care, involves diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions seen in animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor from ears or skin, and change in the texture or color of pet's fur or skin. Itching is commonly seen in companion animals; atopic dermatitis is the common cause of itching.

Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61659

According to a research conducted by the Ferdowsi University of Mashhad Veterinary Teaching Hospital, 20% to 40% of small animals suffered from skin problems in Iran in 2013–2014. Globally, this number may be even higher. Variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing, or ear infections as well as other chronic infections.

Request COVID Analysis on Veterinary Dermatology Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61659

Increase in Medical and Diagnostic Capabilities for Companion Animals to Drive Global Market
The global veterinary dermatology drugs market continues to grow at a rapid pace. The market is driven in developed countries by improved diagnostic and medical capabilities for companion animals. There is a rise in the demand for local anesthetics, anti-inflammatory agents, emollients to treat acne, cleansers, and anti-infectives. Moreover, increase in the demand for veterinary and related products such as dairy and agriculture products and rise in awareness about veterinary dermatology drugs are anticipated to drive the global veterinary dermatology drugs market.
Increase in Ownership of Companion Animals to Fuel Market Growth
Rise in companion animal ownership is a significant trend in the animal healthcare segment. In 2013, around 62% of the U.S. households owned a companion animal (excluding horses) i.e., around 72.9 million homes. Brazil, China, India, Mexico, and Russia are among the top countries with a high growth rate in terms of companion animal ownership.

Buy Veterinary Dermatology Drugs Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=61659<ype=S

Veterinary Dermatology Drugs Market: Prominent Regions
In terms of region, the global veterinary dermatology drugs market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global veterinary dermatology drugs market in 2020, followed by Europe and Asia Pacific. North America is projected to be a highly attractive market from 2021 to 2031. The high revenue from the region can be attributed to the increase in government and private funding and large volume of tests performed. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher, which augments the market. The veterinary dermatology drugs market in Asia Pacific is expected to be driven by availability of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region

Trending Reports of Transparency Market Research –
Teleradiology Services Market –
https://www.biospace.com/article/teleradiology-services-market-is-expected-to-elevate-to-a-value-of-us-19-7-bn-by-the-end-of-2031/

Drug and Gene Delivery Systems Market –
https://www.biospace.com/article/drug-and-gene-delivery-systems-market-size-to-accelerate-at-a-rapid-cagr-of-6-percent-from-2017-to-2025/

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.